Search for Clinical Trial Results

Muscular Dystrophy, Duchenne - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2011-12-22 |
Active, not recruiting |
Study Name: Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2013-08-01 Interventions:
|
Active, not recruiting |
Study Name: Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2015-04-29 Interventions:
|
Completed |
Study Name: Pentoxifylline in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2005-01-29 Interventions: Drug: Pentoxifylline Pentoxifylline dosing: 20mg/Kg/day in a 20 mg/mL solution. Maximum dose of 1200mg/d |
Recruiting |
Study Name: Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2014-07-17 Interventions:
|
Terminated |
Study Name: A Study of Tadalafil for Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2013-05-24 Interventions:
|
Recruiting |
Study Name: Rimeporide in Patients With Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2016-01-26 Interventions: Drug: Rimeporide Cohort 1: |
Completed |
Study Name: Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2006-02-23 Interventions:
|
Completed |
Study Name: Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2001-05-21 Interventions:
|
Active, not recruiting |
Study Name: Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2014-10-30 Interventions: Drug: eteplirsen Eteplirsen 30 mg/kg will be administered as an IV infusion once a week for up to 144 we |